Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (171-180 of 345) with videos related to

Pageof 35
Sort By:
Arthritis Care & Research|December 2, 2017
Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort StudyMirjam K de Vries, Elizabeth V Arkema, Jerker Jonsson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 4, 2018
Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control StudyJordan E Axelrad, Ola Olén, Johan Askling, et al.
The Journal of Rheumatology|February 3, 2015
Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcomeAnn Knight, Karin Hjorton, Christer Sundström, et al.
RMD Open|April 15, 2025
In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesityLiselotte Tidblad, Anton Öberg Sysojev, Bénédicte Delcoigne, et al.
Rheumatology (Oxford, England)|February 8, 2022
Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register dataAndrei Barbulescu, Johan Askling, Katerina Chatzidionysiou, et al.
RMD Open|February 14, 2023
Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from SwedenKarin Bengtsson, Johan Askling, Mattias Lorentzon, et al.
Annals of the Rheumatic Diseases|March 13, 2026
Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs-a Swedish nationwide studyViking Huss, Hannah Bower, Martin Björklund, et al.
Expert Opinion on Biological Therapy|April 11, 2018
Uptake of rheumatology biosimilars in the absence of forced switchingDaniela Di Giuseppe, Thomas Frisell, Sofia Ernestam, et al.
JAMA|October 4, 2012
Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalizationMarie E Holmqvist, Martin Neovius, Jonas Eriksson, et al.
Arthritis and Rheumatism|September 24, 2010
Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohortsSaedis Saevarsdottir, Sara Wedrén, Maria Seddighzadeh, et al.
Pageof 35

Showing results (171-180 of 345) with videos related to

Sort By:
Pageof 35
Arthritis Care & Research|December 2, 2017
Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort StudyMirjam K de Vries, Elizabeth V Arkema, Jerker Jonsson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 4, 2018
Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control StudyJordan E Axelrad, Ola Olén, Johan Askling, et al.
The Journal of Rheumatology|February 3, 2015
Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcomeAnn Knight, Karin Hjorton, Christer Sundström, et al.
RMD Open|April 15, 2025
In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesityLiselotte Tidblad, Anton Öberg Sysojev, Bénédicte Delcoigne, et al.
Rheumatology (Oxford, England)|February 8, 2022
Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register dataAndrei Barbulescu, Johan Askling, Katerina Chatzidionysiou, et al.
RMD Open|February 14, 2023
Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from SwedenKarin Bengtsson, Johan Askling, Mattias Lorentzon, et al.
Annals of the Rheumatic Diseases|March 13, 2026
Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs-a Swedish nationwide studyViking Huss, Hannah Bower, Martin Björklund, et al.
Expert Opinion on Biological Therapy|April 11, 2018
Uptake of rheumatology biosimilars in the absence of forced switchingDaniela Di Giuseppe, Thomas Frisell, Sofia Ernestam, et al.
JAMA|October 4, 2012
Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalizationMarie E Holmqvist, Martin Neovius, Jonas Eriksson, et al.
Arthritis and Rheumatism|September 24, 2010
Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohortsSaedis Saevarsdottir, Sara Wedrén, Maria Seddighzadeh, et al.
Pageof 35